Talis Biomedical (TLIS) Stock Highlights

1.85 | +5.71%

2024-09-18 07:31:30

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

Statistics

Range Today

1.79 1.9

Volume Today 13.9K

Range 1 Year

1.37 9.6

Volume 1 Year 3.81M

Range 3 Year

1.37 119.85

Volume 3 Year 9.15M

Range 10 Year

1.37 508.5

Volume 10 Year 12.3M

Highlights

Market Capitalization 2.86M (micro)

Floating Shares 765.11K

Current Price 1.85

Price To Earnings -0.06

Price To Revenue -93.68

Price To Book 0.06

Earnings Per Share -28.02

Payout Ratio 0%

Performance

Latest +5.71%

1 Month -58.43%

3 Months -79.14%

6 Months -79.69%

1 Year -70.11%

3 Years -98.38%

5 Years -99.57%

10 Years -99.57%

Benchmarks

Market Capitalization

86 / 92

Gross Profits

0 / 85

Total Revenue

82 / 89

Total Rank

84 / 92

Free Cashflow

75 / 90

Performance 5 years

91 / 92

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.